| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.BJC.6604715 |
| P8608 | Fatcat ID | release_vqsqynxmfngdrk7h2euf7wy3bq |
| P932 | PMC publication ID | 2579690 |
| P698 | PubMed publication ID | 18841157 |
| P5875 | ResearchGate publication ID | 23305552 |
| P2093 | author name string | T Maruyama | |
| M Watanabe | |||
| H Fujii | |||
| Y Kawaguchi | |||
| K Kono | |||
| Y Mizukami | |||
| K Kamimura | |||
| P2860 | cites work | Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma | Q28207491 |
| Molecular mechanisms of MHC class I abnormalities and APM components in human tumors | Q30319636 | ||
| Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. | Q33799806 | ||
| Down-regulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression | Q35786324 | ||
| Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma | Q36151380 | ||
| Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide | Q36376346 | ||
| An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma | Q36431817 | ||
| Chemoradiation in the management of esophageal cancer | Q36935105 | ||
| HLA typing demands for peptide-based anti-cancer vaccine | Q37101320 | ||
| Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma | Q37262954 | ||
| Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinoma | Q39985993 | ||
| Clinical impact of HLA class I expression in rectal cancer. | Q40173498 | ||
| HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. | Q40465429 | ||
| DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas | Q40778060 | ||
| Implications for immunosurveillance of altered HLA class I phenotypes in human tumours | Q41370602 | ||
| Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study--JCOG9204. | Q44691624 | ||
| HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer | Q44904388 | ||
| HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. | Q53598603 | ||
| Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival? | Q53613374 | ||
| Radical Lymph Node Dissection for Cancer of the Thoracic Esophagus | Q57702493 | ||
| Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma. | Q65002857 | ||
| HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites | Q70222008 | ||
| Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells | Q71227456 | ||
| Expression and prognostic significance of immunoregulatory molecules in esophageal cancer | Q74013089 | ||
| Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer | Q77620964 | ||
| Down-regulation of HLA class I antigen is an independent prognostic factor for clear cell renal cell carcinoma | Q80029054 | ||
| Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms | Q80184305 | ||
| Prognostic significance of HLA class I expression in osteosarcoma defined by anti-pan HLA class I monoclonal antibody, EMR8-5 | Q80331639 | ||
| Clinical significance of HLA class I heavy chain expression in patients with gastric cancer | Q80626130 | ||
| Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma | Q81383285 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1462-1467 | |
| P577 | publication date | 2008-10-07 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma | |
| P478 | volume | 99 |
| Q64903145 | A method for semi-automated image analysis of HLA class I tumour epithelium expression in rectal cancer. |
| Q35072877 | A versatile technique for the in vivo imaging of human tumor xenografts using near-infrared fluorochrome-conjugated macromolecule probes |
| Q28265651 | Alteration of HLA-F and HLA I antigen expression in the tumor is associated with survival in patients with esophageal squamous cell carcinoma |
| Q33931006 | CD8+ T-cell responses rapidly select for antigen-negative tumor cells in the prostate. |
| Q50960953 | Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. |
| Q42112527 | Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma. |
| Q36849676 | Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma |
| Q34052449 | Clinical implication of HLA class I expression in breast cancer |
| Q43147365 | Clinical implications of human leukocyte antigen class I expression in endometrial cancer |
| Q41862292 | Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I. |
| Q90681174 | Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors |
| Q36645793 | Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patients |
| Q36388523 | Expression of MHC Class I on breast cancer cells correlates inversely with HER2 expression |
| Q50788575 | Expression of PD-L1 and HLA Class I in Esophageal Squamous Cell Carcinoma: Prognostic Factors for Patient Outcome. |
| Q34258479 | HLA class I expression and its alteration by preoperative hyperthermo-chemoradiotherapy in patients with rectal cancer |
| Q64951725 | Higher human lymphocyte antigen class I expression in early-stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes. |
| Q64281080 | Human Leukocyte Antigen Class I and Programmed Death-Ligand 1 Coexpression Is an Independent Poor Prognostic Factor in Adenocarcinoma of the Lung |
| Q45061505 | Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma |
| Q95933555 | Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma |
| Q37827418 | Immunologic biomarkers as correlates of clinical response to cancer immunotherapy |
| Q36100837 | Immunology and Immunotherapy of Head and Neck Cancer |
| Q39308337 | Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options |
| Q38736238 | Immunotherapy for head and neck cancer: the future of treatment? |
| Q35713265 | Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment |
| Q39680556 | Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma |
| Q33762053 | Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis |
| Q64950122 | Phospho‑STAT1 expression as a potential biomarker for anti‑PD‑1/anti‑PD‑L1 immunotherapy for breast cancer. |
| Q37703330 | Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma |
| Q39492021 | Prognostic significance of HLA class I and II expression in patients with diffuse large B cell lymphoma treated with standard chemoimmunotherapy |
| Q83932226 | Prognostic significance of HLA class I expressing in gastric carcinoma defined by monoclonal anti-pan HLA class I antibody, EMR8-5 |
| Q90297712 | Prognostic value of HLA class Ⅰ expression in patients with oral squamous cell carcinoma |
| Q37377808 | The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancer |
| Q34199253 | The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key? |
| Q92783664 | The role of Human leukocyte antigen class I on patient survival in Gastrointestinal cancers: a systematic review and meta- analysis |
| Q46518643 | Therapeutic Implications of the Genetic Landscape of Head and Neck Cancer. |
| Q59358702 | [Immunotherapy - The New Era of Oncology] |
Search more.